Savaria Co. (TSE:SIS – Get Free Report) Director Les Teague sold 5,000 shares of Savaria stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of C$28.92, for a total transaction of C$144,600.00.
Savaria Trading Up 0.1%
TSE:SIS traded up C$0.04 during trading hours on Monday, hitting C$29.26. The stock had a trading volume of 47,967 shares, compared to its average volume of 169,706. Savaria Co. has a one year low of C$19.20 and a one year high of C$30.62. The company has a debt-to-equity ratio of 31.42, a quick ratio of 0.91 and a current ratio of 1.71. The company has a market cap of C$2.10 billion, a price-to-earnings ratio of 26.60, a P/E/G ratio of 42.72 and a beta of 1.06. The business’s 50 day moving average is C$28.88 and its 200-day moving average is C$26.31.
Savaria (TSE:SIS – Get Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The company reported C$0.31 earnings per share for the quarter. The company had revenue of C$235.54 million for the quarter. Savaria had a net margin of 8.50% and a return on equity of 12.41%. Sell-side analysts anticipate that Savaria Co. will post 1.2048518 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
Check Out Our Latest Stock Report on Savaria
Savaria Company Profile
Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.
Further Reading
- Five stocks we like better than Savaria
- The AI Boom Has a Second Act—And It’s Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
- 5 Tech Stocks to Buy on the July Pullback
- Is OpenAI’s IPO Delay a Warning for AI Investors?
Receive News & Ratings for Savaria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Savaria and related companies with MarketBeat.com's FREE daily email newsletter.
